|
CHEK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1837000268855E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28919999999411E-05 |
| Normal-vs-Stage2 |
4.212400E-02 |
| Normal-vs-Stage3 |
6.264300E-03 |
| Normal-vs-Stage4 |
2.989500E-02 |
| Stage1-vs-Stage2 |
9.996400E-01 |
| Stage1-vs-Stage3 |
1.716800E-01 |
| Stage1-vs-Stage4 |
3.066400E-01 |
| Stage2-vs-Stage3 |
2.363200E-01 |
| Stage2-vs-Stage4 |
3.671200E-01 |
| Stage3-vs-Stage4 |
8.413800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55069999951962E-07 |
| Normal-vs-AfricanAmerican |
1.64167999999743E-05 |
| Normal-vs-Asian |
1.176020E-01 |
| Caucasian-vs-AfricanAmerican |
4.201600E-01 |
| Caucasian-vs-Asian |
6.605200E-01 |
| AfricanAmerican-vs-Asian |
8.600000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0893999999938E-05 |
| Normal-vs-Female |
1.50979999613554E-08 |
| Male-vs-Female |
7.92380000000925E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.047900E-04 |
| Normal-vs-Extreme_Weight |
1.330020E-02 |
| Normal-vs-Obese |
6.06509999999671E-05 |
| Normal-vs-Extreme_Obese |
8.112400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.053600E-02 |
| Normal_Weight-vs-Obese |
2.209600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.683600E-01 |
| Extreme_Weight-vs-Obese |
3.281700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.174200E-01 |
| Obese-vs-Extreme_Obese |
2.846800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.302800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.21320000046055E-07 |
| Normal-vs-Age(61-80Yrs) |
2.41850000000099E-05 |
| Normal-vs-Age(81-100Yrs) |
2.811000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.928000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.559800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.740220E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.610200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.78360000002709E-06 |
| Normal-VS-Type2 PRCC |
1.008400E-04 |
| Normal-VS-KIRP CIMP |
2.343500E-03 |
| Normal-VS-Unclassified PRCC |
5.815800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.989800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.504600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.808600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.295100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.218600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.558500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.795700E-03 |
| Normal-vs-N1 |
2.101600E-03 |
| Normal-vs-N2 |
1.024010E-01 |
| N0-vs-N1 |
2.734100E-02 |
| N0-vs-N2 |
3.702000E-01 |
| N1-vs-N2 |
5.943000E-01 |
|
|
